NICHD NEONATAL RESEARCH NETWORK (USA)Background: Post-asphyxial hypothermia is protective in experimental animals; however, there have been no RCT evaluating safety and effectiveness of whole body hypothermia in term infants with HIE.Objective: To assess safety and effectiveness of whole body hypothermia in term infants with moderate and severe HIE.Design/Methods: A RCT was conducted of infants 36 weeks GA admitted 6 h of age with either a) a cord or first (Ͻ1 hour) pH Ͻ7.0 or BD Ͼ16 mEq/dl or b) a perinatal event and need for resuscitation, AND evidence of moderate or severe HIE by a certified examiner. Infants were randomized to normothermia (NORMO) or whole body cooling to 33.5 C esophageal (HYPO) for 72 h followed by rewarming by on site-research personnel using the Cincinnati Sub-Zero system. Primary outcome was death or disability at 18 mos: severe disability defined as ANY: Bayley MDIϽ70, Gross Motor Function (GMF) level 3-5, hearing impairment requiring aids, or blindness or moderate disability defined as MDI 85-70 AND either GMF 2, hearing impairment with no amplification or seizure disorder.Results: Of 798 screened infants, 239 were eligible, and 208 were randomized; 102 to HYPO and 106 to NORMO. Target temperature was achieved in HYPO within 90 min and remained constant throughout 72 h. Adverse events were similar among HYPO infants (nϭ19) and NORMO (nϭ15), pϭ0.38. At 18 mos, primary outcome data were available for 204 of the 208 infants. Death or moderate/severe disability occurred in 45 (45%) infants in HYPO and 64 (62%) in NORMO: Risk Ratio (RR) (95%CI) 0.72 (0.55-0.93) with # needed treat (NNT)ϭ6. The risk of death was 24% in HYPO and 36% in NORMO, RR 0.66 (0.43-1.01). The risk of death or disability after moderate HIE was RR 0.67 (0.44 -1.03) and after severe HIE was 0.82 (0.64 -1.06). For HYPO and NORMO respectively, the risks of disabling CP was 19.7% and 28.6%, RR 0.69 (0.38 -1.26), blindness was 5.5% and 14.3%, RR 0.38(0.12-1.19) and hearing impairment requiring aids was 4.0% and 6.3%, RR 0.64 (0.15-2.75). Conclusions:We have demonstrated the effectiveness and safety of whole body hypothermia in term infants with moderate and severe HIE, defined by rigorous criteria, using certified examiners and trained personnel to implement and monitor the intervention and outcome.
Background: Post-asphyxial hypothermia is protective in experimental animals; however, there have been no RCT evaluating safety and effectiveness of whole body hypothermia in term infants with HIE.Objective: To assess safety and effectiveness of whole body hypothermia in term infants with moderate and severe HIE.Design/Methods: A RCT was conducted of infants 36 weeks GA admitted 6 h of age with either a) a cord or first (Ͻ1 hour) pH Ͻ7.0 or BD Ͼ16 mEq/dl or b) a perinatal event and need for resuscitation, AND evidence of moderate or severe HIE by a certified examiner. Infants were randomized to normothermia (NORMO) or whole body cooling to 33.5 C esophageal (HYPO) for 72 h followed by rewarming by on site-research personnel using the Cincinnati Sub-Zero system. Primary outcome was death or disability at 18 mos: severe disability defined as ANY: Bayley MDIϽ70, Gross Motor Function (GMF) level 3-5, hearing impairment requiring aids, or blindness or moderate disability defined as MDI 85-70 AND either GMF 2, hearing impairment with no amplification or seizure disorder.Results: Of 798 screened infants, 239 were eligible, and 208 were randomized; 102 to HYPO and 106 to NORMO. Target temperature was achieved in HYPO within 90 min and remained constant throughout 72 h. Adverse events were similar among HYPO infants (nϭ19) and NORMO (nϭ15), pϭ0.38. At 18 mos, primary outcome data were available for 204 of the 208 infants. Death or moderate/severe disability occurred in 45 (45%) infants in HYPO and 64 (62%) in NORMO: Risk Ratio (RR) (95%CI) 0.72 (0.55-0.93) with # needed treat (NNT)ϭ6. The risk of death was 24% in HYPO and 36% in NORMO,). The risk of death or disability after moderate HIE was RR 0.67 (0.44 -1.03) and after severe HIE was 0.82 (0.64 -1.06). For HYPO and NORMO respectively, the risks of disabling CP was 19.7% and 28.6%, RR 0.69 (0.38 -1.26), blindness was 5.5% and 14.3%, RR 0.38(0.12-1.19) and hearing impairment requiring aids was 4. 0% and 6.3%,.Conclusions: We have demonstrated the effectiveness and safety of whole body hypothermia in term infants with moderate and severe HIE, defined by rigorous criteria, using certified examiners and trained personnel to implement and monitor the intervention and outcome. 341 NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY (UK)Background: Robust quantitative methods are needed to assess the severity of cerebral injury following perinatal hypoxia-ischaemia and to ascertain the efficacy of neuroprotective therapies.Aim: To compare the prognostic efficacies of early magnetic resonance imaging (MRI) spin-spin (T2) relaxometry and proton (1H) magnetic resonance spectroscopy (MRS) in infants with neonatal encephalopathy (NE).Methods: Twenty-three term infants with NE were studied with MRI and MRS at 2.4Tesla within 5 days of birth (mean age at scan 3.09 (sd 1.35) days). Mean MRI T2s were calculated for basal ganglia (BG) and thalamic (TH) regions of interest. Thalamic metabolite 1H-MRS peak area-ratios were determined using an 8ml cubic voxel (PRESS; echo time 270ms; repeti...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.